U.S. Food and Drug Administration

FDA's Critical Path Initiative

About Critical Path

The Critical Path Initiative is FDA's effort to stimulate and facilitate a national effort to modernize the scientific process through which a potential human drug, biological product, or medical device is transformed from a discovery or "proof of concept" into a medical product. More.

Critical Path Opportunities


Contact Information

FDA's Office of Critical Path Programs
Dr. Rachel Behrman, Director
Dr. Leonard Sacks, Deputy Director
Phone: 301-827-1512
Fax: 301-443-9718
Contact Us


Upcoming Events

Articles of Interest

Past Events